At an Inflection Point in HIV Science: Nicolas Chomont, PhD, Looks Ahead to CROI 2026

Why It Matters

CROI 2026 will set the research agenda for HIV treatment and prevention, influencing clinical guidelines and funding priorities worldwide.

Key Takeaways

• CROI 2026 highlights emerging HIV research themes.
• Long‑acting antiretrovirals dominate treatment discussions.
• Funding cuts challenge HIV programs but innovation persists.
• 243 early‑career scholars receive CROI scholarships.
• Conference fosters global, interdisciplinary collaborations.

Pulse Analysis

Since its inception in 1993, the Conference on Retroviruses and Opportunistic Infections (CROI) has served as the premier venue for unveiling breakthroughs in HIV science. Its rigorous abstract selection ensures that only high‑impact studies reach the stage, making the meeting a bellwether for upcoming treatment guidelines and policy shifts. By gathering clinicians, researchers, and policymakers under one roof, CROI accelerates the translation of laboratory discoveries into real‑world interventions, reinforcing its reputation as a catalyst for global HIV progress.

A central theme for CROI 2026 is the rapid evolution of long‑acting antiretroviral therapies (LA‑ART). Large Phase III trials slated for presentation promise dosing intervals ranging from monthly to bi‑annual injections, potentially reshaping adherence strategies and reducing transmission risk. These advances address long‑standing challenges of daily pill fatigue and viral rebound, positioning LA‑ART as a cornerstone of future treatment paradigms. The data will also inform cost‑effectiveness analyses, guiding payers and health systems in allocating resources toward more sustainable HIV care models.

Amid funding reductions that threaten treatment programs and research grants, CROI’s commitment to nurturing the next generation of scientists is more critical than ever. The conference’s scholarship program supports 243 early‑career investigators, fostering diverse, cross‑disciplinary collaborations that can offset resource constraints. By facilitating connections across continents, CROI helps build resilient research networks capable of sustaining momentum despite financial headwinds. This collaborative spirit not only safeguards ongoing innovation but also ensures that emerging solutions reach the populations most in need, reinforcing the global fight against HIV.